Data Quality Act: CRE Submits Comments to CDC/ATSDR on its Data Quality Guidelines
CRE has provided specific written comments to CDC on its proposed Data Quality guidelines. In addition to its letter comments, the Center has attached two papers: (1) a set of CRE Generic Comments to all agencies on their Data Quality guidelines which discuss a variety of important cross-cutting issues; and (2) a Legal Memorandum challenging the OMB's and other agencies' attempts to exempt certain categories of information from the Data Quality Act guidelines' applicability.

Data Quality Act: CRE Submits Comments to FDA on its Data Quality Guidelines
CRE has provided specific written comments to the Food and Drug Administration (FDA) on its proposed Data Quality guidelines. In addition to its letter comments, the Center has attached three papers: (1) a set of CRE Generic Comments to all agencies on their Data Quality guidelines which discuss a variety of important cross-cutting issues; (2) a Legal Memorandum challenging the OMB's and other agencies= attempts to exempt certain categories of information from the Data Quality Act guidelines' applicability; and (3) CRE's earlier letter to FDA recommending applicability of the Data Quality guidelines to the activities of the interagency Risk Assessment Consortium which deals with food safety risks.

Data Quality Act: CRE Requests HHS/FDA Data Quality Guidelines Address Reduced Risk Initiatives
CRE has written HHS to request that, in view of the FDA's responsibilities as Chair of the federal interagency Risk Assessment Consortium (RAC), the Department should ensure uniform, government-wide Data Quality standards for evaluating risk reduction initiatives.